Literature DB >> 16650209

Wound-healing trajectories as outcome measures of venous stasis ulcer treatment.

David L Steed1, Donald P Hill, Matthew E Woodske, Wyatt G Payne, Martin C Robson.   

Abstract

Outcome measures of venous ulcer healing are not uniformly accepted. Stringent criteria of 100% closure fail to provide information of healing over the entire span of repair. Wound-healing trajectories (plot of percentage of wound closure versus time of wound treatment) were constructed for 232 patients treated in eight clinical trials at two independent wound care/research centres. Trajectories were constructed for ulcers that totally healed (100% closure) and those that did not (<100% closure) over a 20-week period. Kaplan-Meier survival plots determined the percentage of patients achieving total healing versus time of treatment. The wound-healing trajectories were almost identical for patients achieving complete ulcer healing, as were the trajectories for patients with less than 100% closure. The trajectories for the ulcers healing completely were significantly different from those with <100% closure. Only 60% of all patients achieved 100% closure by 20 weeks. Using linear regression, it was predicted that it would take 31 weeks for all patients to achieve total healing. Total healing is an inadequate outcome measure for healing of venous stasis ulcers. Clinical trials using this measure would require excessive time periods. As wound-healing trajectories for patients treated at two centres mimic one another, shifting the wound-healing trajectory from one of impaired healing to one of a more ideal healing course may be considered a better outcome measure for determining healing of venous stasis ulcers.

Entities:  

Mesh:

Year:  2006        PMID: 16650209      PMCID: PMC7951476          DOI: 10.1111/j.1742-4801.2006.00178.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  31 in total

1.  Guidance for industry: chronic cutaneous ulcer and burn wounds-developing products for treatment.

Authors: 
Journal:  Wound Repair Regen       Date:  2001 Jul-Aug       Impact factor: 3.617

Review 2.  Chronic venous ulcer.

Authors:  N Angle; J J Bergan
Journal:  BMJ       Date:  1997-04-05

Review 3.  Topical growth factors and wound contraction in the rat: Part I. Literature review and definition of the rat model.

Authors:  K J Richey; L H Engrav; E G Pavlin; M J Murray; J R Gottlieb; M D Walkinshaw
Journal:  Ann Plast Surg       Date:  1989-08       Impact factor: 1.539

4.  Safety and effect of transforming growth factor-beta(2) for treatment of venous stasis ulcers.

Authors:  M C Robson; L G Phillip; D M Cooper; W G Lyle; L E Robson; L Odom; D P Hill; A F Hanham; G A Ksander
Journal:  Wound Repair Regen       Date:  1995 Apr-Jun       Impact factor: 3.617

5.  Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study.

Authors:  J W Olin; K M Beusterien; M B Childs; C Seavey; L McHugh; R I Griffiths
Journal:  Vasc Med       Date:  1999       Impact factor: 3.239

6.  Wound geometry and the kinetics of wound contraction.

Authors:  M H McGrath; R H Simon
Journal:  Plast Reconstr Surg       Date:  1983-07       Impact factor: 4.730

7.  A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.

Authors:  V Falanga; M Sabolinski
Journal:  Wound Repair Regen       Date:  1999 Jul-Aug       Impact factor: 3.617

8.  Initial rate of healing predicts complete healing of venous ulcers.

Authors:  P Tallman; E Muscare; P Carson; W H Eaglstein; V Falanga
Journal:  Arch Dermatol       Date:  1997-10

9.  Chronology and determinants of tissue repair in diabetic lower-extremity ulcers.

Authors:  R E Pecoraro; J H Ahroni; E J Boyko; V L Stensel
Journal:  Diabetes       Date:  1991-10       Impact factor: 9.461

Review 10.  Leg ulcers.

Authors:  T J Phillips; J S Dover
Journal:  J Am Acad Dermatol       Date:  1991-12       Impact factor: 11.527

View more
  6 in total

1.  Cost-effectiveness of treating vascular leg ulcers with UrgoStart(®) and UrgoCell(®) Contact.

Authors:  Matthias Augustin; Katharina Herberger; Knut Kroeger; Karl C Muenter; Lisa Goepel; Reinhard Rychlik
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

2.  A single-arm trial indirect comparison investigation: a proof-of-concept method to predict venous leg ulcer healing time for a new acellular synthetic matrix matched to standard care control.

Authors:  Ronald Shannon; Andrea Nelson
Journal:  Int Wound J       Date:  2016-11-20       Impact factor: 3.315

3.  Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.

Authors:  Jean-Luc Schmutz; Sylvie Meaume; Ségolène Fays; Zohva Ourabah; Bernard Guillot; Valéne Thirion; Mark Collier; Simon Barrett; J Smith; Serge Bohbot; Anne Dompmartin
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

4.  The impact of Manuka honey dressings on the surface pH of chronic wounds.

Authors:  Georgina T Gethin; Seamus Cowman; Ronan M Conroy
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

5.  Wound healing trajectories to determine pressure ulcer treatment efficacy.

Authors:  Wyatt G Payne; Rajat Bhalla; Donald P Hill; Yvonne N Pierpont; Martin C Robson
Journal:  Eplasty       Date:  2011-01-10

6.  Measuring progress to healing: A challenge and an opportunity.

Authors:  Richard Hillson Bull; Karen Louise Staines; Agnes Juguilon Collarte; Duncan Shirreffs Bain; Nicola M Ivins; Keith Gordon Harding
Journal:  Int Wound J       Date:  2021-08-10       Impact factor: 3.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.